Biegel & Waller’s Bristol-Myers Squibb BMY Stock Holding History

Biegel & Waller’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$269K	Buy	5,300 +500	+10%	+$23.5K	0.15%	59
2019 Q2	$218K	Sell	4,800 -767	-14%	-$35.7K	0.11%	70
2019 Q1	$266K	Sell	5,567 -167	-3%	-$8.32K	0.14%	62
2018 Q4	$298K	Hold	5,734	–	–	0.18%	48
2018 Q3	$356K	Buy	5,734 +67	+1%	+$3.98K	0.21%	45
2018 Q2	$314K	Hold	5,667	–	–	0.2%	47
2018 Q1	$358K	Hold	5,667	–	–	0.23%	32
2017 Q4	$347K	Sell	5,667 -253	-4%	-$15.8K	0.2%	35
2017 Q3	$377K	Hold	5,920	–	–	0.24%	31
2017 Q2	$330K	Hold	5,920	–	–	0.2%	35
2017 Q1	$322K	Hold	5,920	–	–	0.22%	31
2016 Q4	$277K	Buy	+5,920	New	+$324K	0.19%	34

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Biegel & Waller's BMY Position: Q3 2019 in Review

Biegel & Waller increased its Bristol-Myers Squibb (BMY) stake by 10% in Q3 2019, buying an estimated $23.5K and bringing the position to 5,300 shares worth $269K. The position accounts for 0.15% of the portfolio, ranked #59.

Biegel & Waller first reported a position in BMY in Q4 2016 and has held it in 12 quarters since. The position peaked at $377K in Q3 2017. 1,814 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

Biegel & Waller held 5,300 shares of Bristol-Myers Squibb worth $269K as of Q3 2019.
Biegel & Waller bought 500 Bristol-Myers Squibb shares in Q3 2019, an estimated $23.5K.
Bristol-Myers Squibb made up 0.15% of Biegel & Waller's portfolio in Q3 2019, its #59 holding.
Biegel & Waller first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 12 quarters since.
Biegel & Waller's Bristol-Myers Squibb position peaked at $377K in Q3 2017.
1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Biegel & Waller's 13F filing for Q3 2019, filed 15 Oct 2019.